These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31731110)

  • 1. Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis.
    de Carvalho Reis R; Almeida KJ; da Silva Lopes L; de Melo Mendes CM; Bor-Seng-Shu E
    Epilepsy Behav; 2020 Jan; 102():106635. PubMed ID: 31731110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic use of medicinal cannabis in difficult to manage epilepsy.
    Lawson JA; Scheffer IE
    Br J Clin Pharmacol; 2018 Nov; 84(11):2488-2490. PubMed ID: 30088286
    [No Abstract]   [Full Text] [Related]  

  • 4. Cannabis and Endocannabinoid Signaling in Epilepsy.
    Katona I
    Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis-based products for pediatric epilepsy: A systematic review.
    Elliott J; DeJean D; Clifford T; Coyle D; Potter BK; Skidmore B; Alexander C; Repetski AE; Shukla V; McCoy B; Wells GA
    Epilepsia; 2019 Jan; 60(1):6-19. PubMed ID: 30515765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol for Epilepsy: New Hope on the Horizon?
    Sanmartin PE; Detyniecki K
    Clin Ther; 2018 Sep; 40(9):1438-1441. PubMed ID: 30150078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study.
    Hausman-Kedem M; Menascu S; Kramer U
    Brain Dev; 2018 Aug; 40(7):544-551. PubMed ID: 29674131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
    Reddy DS
    Clin Pharmacol Ther; 2017 Feb; 101(2):182-184. PubMed ID: 27506704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next.
    Rubin R
    JAMA; 2018 Sep; 320(12):1227-1229. PubMed ID: 30193358
    [No Abstract]   [Full Text] [Related]  

  • 12. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
    Devinsky O; Marsh E; Friedman D; Thiele E; Laux L; Sullivan J; Miller I; Flamini R; Wilfong A; Filloux F; Wong M; Tilton N; Bruno P; Bluvstein J; Hedlund J; Kamens R; Maclean J; Nangia S; Singhal NS; Wilson CA; Patel A; Cilio MR
    Lancet Neurol; 2016 Mar; 15(3):270-8. PubMed ID: 26724101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis-based products for pediatric epilepsy: An updated systematic review.
    Elliott J; DeJean D; Clifford T; Coyle D; Potter BK; Skidmore B; Alexander C; Repetski AE; Shukla V; McCoy B; Wells GA
    Seizure; 2020 Feb; 75():18-22. PubMed ID: 31865133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
    Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
    Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of cannabis for treating children with refractory epilepsy.
    Neale M
    Nurs Child Young People; 2017 Sep; 29(7):32-37. PubMed ID: 29115760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of cannabidiol-enriched medical cannabis in a prospective cohort of children with drug-resistant developmental and epileptic encephalopathy.
    Caraballo R; Reyes G; Demirdjian G; Huaman M; Gutierrez R
    Seizure; 2022 Feb; 95():56-63. PubMed ID: 34999381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol as potential treatment in refractory pediatric epilepsy.
    Paolino MC; Ferretti A; Papetti L; Villa MP; Parisi P
    Expert Rev Neurother; 2016; 16(1):17-21. PubMed ID: 26567560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use.
    Suraev AS; Todd L; Bowen MT; Allsop DJ; McGregor IS; Ireland C; Lintzeris N
    Epilepsy Behav; 2017 May; 70(Pt B):334-340. PubMed ID: 28238865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.
    Lattanzi S; Brigo F; Trinka E; Zaccara G; Cagnetti C; Del Giovane C; Silvestrini M
    Drugs; 2018 Nov; 78(17):1791-1804. PubMed ID: 30390221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.